Shared equipment – Page 6

Worst-Case Product Selection for High-Dose vs Low-Dose Products

Identifying Risks in High-Dose versus Low-Dose Drug Manufacturing In pharmaceutical manufacturing, particularly where products with varying dosages are produced, the selection of a worst-case scenario is paramount to ensure compliance…

How to Use MACO Data in Cross-Contamination Deviation Assessment

Utilizing MACO Data for Effective Assessment of Cross-Contamination Deviations Cleanliness is paramount in pharmaceutical manufacturing, where the risk of cross-contamination can lead to serious quality issues and regulatory infractions. A…

Worst-Case Product Selection for Low-Solubility APIs: Practical Examples

Addressing Challenges in Worst-Case Product Selection for Low-Solubility APIs Pharmaceutical manufacturers face numerous challenges when it comes to the selection of worst-case products, especially for low-solubility APIs. These challenges often…

Cleaning and Cross-Contamination CAPA Effectiveness Verification

Effective Verification of CAPA for Cleaning and Cross-Contamination Issues In the pharmaceutical manufacturing environment, contending with cleaning and cross-contamination deviations is a critical aspect of maintaining product integrity and compliance…

How to Justify Bracketing of Worst-Case Products in Cleaning Validation

Justifying Bracketing of Worst-Case Products in Cleaning Validation Cleaning validation is a critical component in the pharmaceutical manufacturing process, ensuring that equipment is free from undesirable residues when transitioning between…

Cross-Contamination Risk from Incomplete Equipment Disassembly

Addressing Cross-Contamination Risks Due to Inadequate Equipment Disassembly In pharmaceutical manufacturing, the risk of cross-contamination poses significant challenges, particularly due to incomplete equipment disassembly during cleaning processes. This issue can…

Worst-Case Product Selection When Product Portfolio Changes After Validation

Challenges of Worst-Case Product Selection Amid Changes in Product Portfolio In the dynamic landscape of pharmaceutical manufacturing, product portfolio changes can significantly impact contamination control strategies, particularly in the context…

Worst-Case Product Selection When Product Portfolio Changes After Validation

Strategies for Addressing Worst-Case Product Selection in Changed Portfolios Pharmaceutical manufacturers frequently face challenges when product portfolios evolve, particularly in relation to cleaning and contamination control. A scenario may arise…

Cleaning Deviation Caused by Wrong Equipment Status Label

Addressing Cleaning Deviations Due to Incorrect Equipment Status Labels In pharmaceutical manufacturing, accurate cleaning protocols are essential for ensuring product safety and compliance with GMP (Good Manufacturing Practices). A common…

How Batch Size and Dose Strength Affect Worst-Case Cleaning Validation Decisions

Understanding How Batch Size and Dose Strength Influence Worst-Case Cleaning Validation Decisions In the pharmaceutical manufacturing environment, ensuring effective cleaning processes is critical to maintaining compliance and product quality. When…

Cross-Contamination Risk from Gaskets, Hoses, and Equipment Accessories

Managing Cross-Contamination Risks in Pharmaceutical Equipment: Gaskets, Hoses, and Accessories In the pharmaceutical manufacturing environment, cross-contamination poses a serious threat to product quality and patient safety. One critical issue that…

How to Include Equipment Surface Area in Worst-Case Product Selection

Effective Strategies for Integrating Equipment Surface Area in Worst-Case Product Selection In the realm of pharmaceutical manufacturing, worst-case product selection is a crucial step to ensure that cleaning processes effectively…